HHLR ADVISORS, LTD.
SuperinvestorHHLR Advisors (Hillhouse)
- SEC CIK
- 0001762304
- Manager
- Zhang Lei
- Style
- Growth
MREO holding history
Mereo BioPharma Group plc
Every 13F filing in which HHLR Advisors (Hillhouse) reported holding MREO, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.
MREO overviewAll 13F holders of MREOFull portfolio
| Quarter | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.00% | −2,976,121−100.0% | Sold out |
| Q1 2022 | 2,976,121 | $3.33M | 0.07% | 00.0% | Unchanged |
| Q4 2021 | 2,976,121 | $4.76M | 0.07% | 00.0% | Unchanged |
| Q3 2021 | 2,976,121 | $7.2M | 0.09% | 00.0% | Unchanged |
| Q2 2021 | 2,976,121 | $9.43M | 0.10% | 00.0% | Unchanged |
| Q1 2021 | 2,976,121 | $10.03M | 0.10% | +2,976,121 | New |